Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (13)

2024

  1. Serum Amyloid A as a Potential Biomarker for Disease Activity in Chronic Spontaneous Urticaria

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 1, pp. 195-200

2022

  1. A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 191-199

  2. Angioedema severity and impact on quality of life: Chronic histaminergic angioedema versus chronic spontaneous urticaria

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 11, pp. 3039-3043.e3

  3. Consensus on the Definition of Control and Remission in Chronic Urticaria

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 4, pp. 261-269

2021

  1. A Comparative Study of Sex Distribution, Autoimmunity, Blood, and Inflammatory Parameters in Chronic Spontaneous Urticaria with Angioedema and Chronic Histaminergic Angioedema

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 6, pp. 2284-2292

  2. Erratum to “IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper” [World Allergy Organ J 13/2 (2020) 100080] (World Allergy Organization Journal (2020) 13(2), (S1939455119312360), (10.1016/j.waojou.2019.100080))

    World Allergy Organization Journal

2020

  1. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

    World Allergy Organization Journal, Vol. 13, Núm. 2

2019

  1. Efficacy and Safety of Omalizumab (Xolair) for Cholinergic Urticaria in Patients Unresponsive to a Double Dose of Antihistamines: A Randomized Mixed Double-Blind and Open-Label Placebo-Controlled Clinical Trial

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 5, pp. 1599-1609.e1

  2. Therapeutic strategy according to differences in response to omalizumab in patients with chronic spontaneous urticaria giménez

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 5, pp. 338-348

2015

  1. Are all new allergens in TRUE Test® essential for a baseline set?

    Contact Dermatitis

2014

  1. Assessment of severity and quality of life in chronic urticaria

    Journal of Investigational Allergology and Clinical Immunology, Vol. 24, Núm. 2, pp. 80-86

  2. Management of angioedema without urticaria in the emergency department

    Annals of Medicine, Vol. 46, Núm. 8, pp. 607-618

2012

  1. Research needs in allergy: An EAACI position paper, in collaboration with EFA

    Clinical and Translational Allergy, Vol. 2, Núm. 1